Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RYAN
RYAN logo

RYAN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ryan Specialty Holdings Inc (RYAN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
33.350
1 Day change
-1.16%
52 Week Range
77.160
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ryan Specialty Holdings Inc (RYAN) is not a strong buy right now for a beginner investor with a long-term focus. The stock is in a bearish technical trend, with weak financial performance in the latest quarter and no significant positive catalysts. While hedge funds are buying, the lack of recent news, declining analyst price targets, and weak earnings growth suggest caution. For a long-term investor, it would be better to wait for clearer signs of recovery or stability before investing.

Technical Analysis

The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI at 5.629 indicating oversold conditions, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). The current price is below the pivot level of 34.897, with support at 33.113 and resistance at 36.681.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
1

Positive Catalysts

  • Hedge funds are buying significantly, with a 53579.79% increase in buying activity over the last quarter.

Neutral/Negative Catalysts

  • Declining analyst price targets, weak financial performance with a 47.13% drop in net income YoY, and no recent news or significant insider trading activity. The stock is also facing cyclical pricing pressure and concerns about AI-driven disruption in the insurance brokerage sector.

Financial Performance

In Q4 2025, revenue increased by 13.21% YoY to $751.2M, but net income dropped by 47.13% YoY to $7.98M. EPS fell significantly by 111.76% YoY to 0.06. Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have generally lowered their price targets, with the most recent target at $55 from Citi, down from $60. The consensus sentiment is mixed, with some analysts maintaining Buy or Overweight ratings but lowering targets due to slower growth, margin concerns, and fears of AI-driven disruption.

Wall Street analysts forecast RYAN stock price to rise
16 Analyst Rating
Wall Street analysts forecast RYAN stock price to rise
10 Buy
5 Hold
1 Sell
Moderate Buy
Current: 33.740
sliders
Low
56
Averages
64.57
High
82
Current: 33.740
sliders
Low
56
Averages
64.57
High
82
Citi
Buy
downgrade
$60 -> $55
AI Analysis
2026-03-23
Reason
Citi
Price Target
$60 -> $55
AI Analysis
2026-03-23
downgrade
Buy
Reason
Citi lowered the firm's price target on Ryan Specialty to $55 from $60 and keeps a Buy rating on the shares. The firm sees cyclical pricing pressure impacting the company's wholesale growth.
Barclays
Overweight
maintain
$52 -> $45
2026-03-11
Reason
Barclays
Price Target
$52 -> $45
2026-03-11
maintain
Overweight
Reason
Barclays lowered the firm's price target on Ryan Specialty to $45 from $52 and keeps an Overweight rating on the shares. The insurance broker group has "derated sharply on fears of AI-driven disruption," the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now "more than discount" slower growth while overlooking durability of the broker business model and AI's potential to support productivity and margins. The analyst views AI as a "productivity enabler" for the brokers.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RYAN
Unlock Now

People Also Watch